Imaging of Kidney Cancer

Radiologic Clinics of North America

Volumn 45, Issue 1, 2007, Pages 119-147

  Zhang, Jingbo ^a   Lefkowitz, Robert A ^a   Bach, Ariadne ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; BISPHOSPHONIC ACID DERIVATIVE; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; HEAVY METAL; PETROLEUM DERIVATIVE;

ANGIOSARCOMA; BODY MASS; BONE METASTASIS; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CHONDROSARCOMA; CLEAR CELL CARCINOMA; CLEAR CELL SARCOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CRYOSURGERY; CRYOTHERAPY; CYTOGENETICS; ECHOGRAPHY; GRANULAR CELL TUMOR; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY CANCER; KIDNEY CARCINOMA; KIDNEY SARCOMA; LUNG METASTASIS; LYMPHOMA; MALIGNANT FIBROUS HISTIOCYTOMA; NEPHRECTOMY; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL EXPOSURE; OSTEOSARCOMA; PATHOGENESIS; PATIENT COUNSELING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; RISK FACTOR; SCINTIGRAPHY; SOLID TUMOR; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING; UROGENITAL TRACT CANCER; VON HIPPEL LINDAU DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FALSE POSITIVE REACTIONS; FOLLOW-UP STUDIES; HUMANS; KIDNEY; KIDNEY NEOPLASMS; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MESENCHYMOMA; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 33845189250     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2006.10.011     Document Type: Review

References (180)

1. American Cancer Society. Cancer facts and figures 2006 (2006), American Cancer Society, Atlanta (GA)
2. Ries L.A.G., Eisner M.P., Kosary C.L., et al. SEER cancer statistics review, 1975-2002 (2005), National Cancer Institute, Bethesda (MD)
3. Provet J., Tessler A., Brown J., et al. Partial nephrectomy for renal cell carcinoma: indications, results and implications. J Urol 145 3 (1991) 472-476
4. Kosary C.L., and McLaughlin J.K. Kidney and renal pelvis. In: Miller B.A., Ries L.A.G., Hankey B.G., et al. (Eds). SEER cancer statistics review, 1973-1990. NIH publication no. 93-2789, XI.1-XI.22 (1993), National Cancer Institute, Bethesda (MD)
5. Bosniak M.A. Problems in the radiologic diagnosis of renal parenchymal tumors. Urol Clin North Am 20 2 (1993) 217-230
6. Bosniak M.A. Observation of small incidentally detected renal masses. Semin Urol Oncol 13 4 (1995) 267-272
7. Bosniak M.A., Birnbaum B.A., Krinsky G.A., et al. Small renal parenchymal neoplasms: further observations on growth. Radiology 197 3 (1995) 589-597
8. Kassouf W., Aprikian A.G., Laplante M., et al. Natural history of renal masses followed expectantly. J Urol 171 1 (2004) 111-113 [discussion 113]
9. Motzer R.J., Russo P., Nanus D.M., and Berg W.J. Renal cell carcinoma. Curr Probl Cancer 21 4 (1997) 185-232
10. Russo P. Renal cell carcinoma: presentation, staging, and surgical treatment. Semin Oncol 27 2 (2000) 160-176
11. Smith S.J., Bosniak M.A., Megibow A.J., et al. Renal cell carcinoma: earlier discovery and increased detection. Radiology 170 3 Pt 1 (1989) 699-703
12. Rabbani F., Reuter V.E., Katz J., et al. Second primary malignancies associated with renal cell carcinoma: influence of histologic type. Urology 56 3 (2000) 399-403
13. Weiss L.M., Gelb A.B., and Medeiros L.J. Adult renal epithelial neoplasms. Am J Clin Pathol 103 5 (1995) 624-635
14. Kovacs G., Akhtar M., Beckwith B.J., et al. The Heidelberg classification of renal cell tumours. J Pathol 183 2 (1997) 131-133
15. Russo P. Evolving understanding and surgical management of renal cortical tumors. Mayo Clin Proc 75 12 (2000) 1233-1235
16. Russo P. Localized renal cell carcinoma. Curr Treat Options Oncol 2 5 (2001) 447-455
17. Lindblad P., Mellemgaard A., Schlehofer B., et al. International renal-cell cancer study: V. reproductive factors, gynecologic operations and exogenous hormones. Int J Cancer 61 2 (1995) 192-198
18. Mandel J.S., McLaughlin J.K., Schlehofer B., et al. International renal-cell cancer study: IV. occupation. Int J Cancer 61 5 (1995) 601-605
19. McLaughlin J.K., Chow W.H., Mandel J.S., et al. International renal-cell cancer study: VIII. role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer 63 2 (1995) 216-221
20. McLaughlin J.K., Lindblad P., Mellemgaard A., et al. International renal-cell cancer study: I. tobacco use. Int J Cancer 60 2 (1995) 194-198
21. Mellemgaard A., Lindblad P., Schlehofer B., et al. International renal-cell cancer study: III. role of weight, height, physical activity, and use of amphetamines. Int J Cancer 60 3 (1995) 350-354
22. Schlehofer B., Pommer W., Mellemgaard A., et al. International renal-cell-cancer study: VI. the role of medical and family history. Int J Cancer 66 6 (1996) 723-726
23. Wolk A., Gridley G., Niwa S., et al. International renal cell cancer study: VII. Role of diet. Int J Cancer 65 1 (1996) 67-73
24. Ishikawa I., and Kovacs G. High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histopathology 22 2 (1993) 135-139
25. Rabbani F., Herr H.W., Almahmeed T., et al. Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors. J Clin Oncol 20 9 (2002) 2370-2375
26. Lamiell J.M., Salazar F.G., and Hsia Y.E. von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore) 68 1 (1989) 1-29
27. Cohen A.J., Li F.P., Berg S., et al. Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med 301 11 (1979) 592-595
28. Pathak S., Strong L.C., Ferrell R.E., et al. Familial renal cell carcinoma with a 3;11 chromosome translocation limited to tumor cells. Science 217 4563 (1982) 939-941
29. Motzer R.J., Bander N.H., and Nanus D.M. Renal-cell carcinoma. N Engl J Med 335 12 (1996) 865-875
30. Beck S.D., Patel M.I., Snyder M.E., et al. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol 11 1 (2004) 71-77
31. Eble J.N., and Bonsib S.M. Extensively cystic renal neoplasms: cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma, and cystic hamartoma of renal pelvis. Semin Diagn Pathol 15 1 (1998) 2-20
32. McKiernan J., Yossepowitch O., Kattan M.W., et al. Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome. Urology 60 6 (2002) 1003-1009
33. Motzer R.J., Bacik J., Mariani T., et al. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol 20 9 (2002) 2376-2381
34. Amin M.B., Corless C.L., Renshaw A.A., et al. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol 21 6 (1997) 621-635
35. Renshaw A.A., Henske E.P., Loughlin K.R., et al. Aggressive variants of chromophobe renal cell carcinoma. Cancer 78 8 (1996) 1756-1761
36. Crotty T.B., Farrow G.M., and Lieber M.M. Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. J Urol 154 3 (1995) 964-967
37. Kondagunta G.V., Drucker B., Schwartz L., et al. Phase II trial of bortezomib for patients with advanced renal cell carcinoma. J Clin Oncol 22 18 (2004) 3720-3725
38. Ficarra V., Righetti R., Pilloni S., et al. Prognostic factors in patients with renal cell carcinoma: retrospective analysis of 675 cases. Eur Urol 41 2 (2002) 190-198
39. Frank I., Blute M.L., Cheville J.C., et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168 6 (2002) 2395-2400
40. Gettman M.T., Blute M.L., Spotts B., et al. Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system. Cancer 91 2 (2001) 354-361
41. Bretheau D., Lechevallier E., de Fromont M., et al. Prognostic value of nuclear grade of renal cell carcinoma. Cancer 76 12 (1995) 2543-2549
42. Ficarra V., Righetti R., Martignoni G., et al. Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases. Urol Int 67 2 (2001) 130-134
43. Fiori E., De Cesare A., Galati G., et al. Prognostic significance of primary-tumor extension, stage and grade of nuclear differentiation in patients with renal cell carcinoma. J Exp Clin Cancer Res 21 2 (2002) 229-232
44. Fuhrman S.A., Lasky L.C., and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 7 (1982) 655-663
45. Lohse C.M., Blute M.L., Zincke H., et al. Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients. Am J Clin Pathol 118 6 (2002) 877-886
46. Ficarra V., Guille F., Schips L., et al. Proposal for revision of the TNM classification system for renal cell carcinoma. Cancer 104 10 (2005) 2116-2123
47. Gudbjartsson T., Hardarson S., Petursdottir V., et al. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Eur Urol 48 (2005) 593-600
48. Patel M.I., Simmons R., Kattan M.W., et al. Long-term follow-up of bilateral sporadic renal tumors. Urology 61 5 (2003) 921-925
49. Richstone L., Scherr D.S., Reuter V.R., et al. Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival. J Urol 171 2 Pt 1 (2004) 615-620
50. Silver D.A., Morash C., Brenner P., et al. Pathologic findings at the time of nephrectomy for renal mass. Ann Surg Oncol 4 7 (1997) 570-574
51. Dechet C.B., Zincke H., Sebo T.J., et al. Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J Urol 169 1 (2003) 71-74
52. Lechevallier E., Andre M., Barriol D., et al. Fine-needle percutaneous biopsy of renal masses with helical CT guidance. Radiology 216 2 (2000) 506-510
53. Herts B.R., Coll D.M., Novick A.C., et al. Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am J Roentgenol 178 2 (2002) 367-372
54. Jinzaki M., Tanimoto A., Mukai M., et al. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 24 6 (2000) 835-842
55. Kim J.K., Kim T.K., Ahn H.J., et al. Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol 178 6 (2002) 1499-1506
56. Press G.A., McClennan B.L., Melson G.L., et al. Papillary renal cell carcinoma: CT and sonographic evaluation. AJR Am J Roentgenol 143 5 (1984) 1005-1009
57. Ruppert-Kohlmayr A.J., Uggowitzer M., Meissnitzer T., et al. Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters. AJR Am J Roentgenol 183 5 (2004) 1387-1391
58. Sheir K.Z., El-Azab M., Mosbah A., et al. Differentiation of renal cell carcinoma subtypes by multislice computerized tomography. J Urol 174 2 (2005) 451-455 [discussion 455]
59. Israel G.M., and Bosniak M.A. Renal imaging for diagnosis and staging of renal cell carcinoma. Urol Clin North Am 30 3 (2003) 499-514
60. Silverman S.G., Lee B.Y., Seltzer S.E., et al. Small (< or = 3 cm) renal masses: correlation of spiral CT features and pathologic findings. AJR Am J Roentgenol 163 3 (1994) 597-605
61. Kauczor H.U., Schwickert H.C., Schweden F., et al. Bolus-enhanced renal spiral CT: technique, diagnostic value and drawbacks. Eur J Radiol 18 3 (1994) 153-157
62. Sheth S., Scatarige J.C., Horton K.M., et al. Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector ct and three-dimensional CT. Radiographics 21 Spec No (2001) S237-S254
63. Schreyer H.H., Uggowitzer M.M., and Ruppert-Kohlmayr A. Helical CT of the urinary organs. Eur Radiol 12 3 (2002) 575-591
64. Yuh B.I., Cohan R.H., Francis I.R., et al. Comparison of nephrographic with excretory phase helical computed tomography for detecting and characterizing renal masses. Can Assoc Radiol J 51 3 (2000) 170-176
65. Yuh B.I., and Cohan R.H. Different phases of renal enhancement: role in detecting and characterizing renal masses during helical CT. AJR Am J Roentgenol 173 3 (1999) 747-755
66. Yuh B.I., and Cohan R.H. Helical CT for detection and characterization of renal masses. Semin Ultrasound CT MR 18 2 (1997) 82-90
67. Szolar D.H., Kammerhuber F., Altziebler S., et al. Multiphasic helical CT of the kidney: increased conspicuity for detection and characterization of small (<3-cm) renal masses. Radiology 202 1 (1997) 211-217
68. Cohan R.H., Sherman L.S., Korobkin M., et al. Renal masses: assessment of corticomedullary-phase and nephrographic-phase CT scans. Radiology 196 2 (1995) 445-451
69. Birnbaum B.A., Jacobs J.E., and Ramchandani P. Multiphasic renal CT: comparison of renal mass enhancement during the corticomedullary and nephrographic phases. Radiology 200 3 (1996) 753-758
70. Kopka L., Fischer U., Zoeller G., et al. Dual-phase helical CT of the kidney: value of the corticomedullary and nephrographic phase for evaluation of renal lesions and preoperative staging of renal cell carcinoma. AJR Am J Roentgenol 169 6 (1997) 1573-1578
71. Zhang J, Lefkowitz R, Ishill N, et al. Differentiation of solid renal cortical tumors by CT. Radiology, in press.
72. Ambos M.A., Bosniak M.A., Valensi Q.J., et al. Angiographic patterns in renal oncocytomas. Radiology 129 3 (1978) 615-622
73. Quinn M.J., Hartman D.S., Friedman A.C., et al. Renal oncocytoma: new observations. Radiology 153 1 (1984) 49-53
74. Jinzaki M., Tanimoto A., Narimatsu Y., et al. Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology 205 2 (1997) 497-502
75. Daniel W.W., Hartman G.W., Witten D.M., et al. Calcified renal mass: a review of ten years experience at the Mayo Clinic. Radiology 103 (1972) 503-508
76. Bosniak M.A. The current radiological approach to renal cysts. Radiology 158 1 (1986) 1-10
77. Brinker D.A., Amin M.B., de Peralta-Venturina M., et al. Extensively necrotic cystic renal cell carcinoma: a clinicopathologic study with comparison to other cystic and necrotic renal cancers. Am J Surg Pathol 24 7 (2000) 988-995
78. Birnbaum B.A., Maki D.D., Chakraborty D.P., et al. Renal cyst pseudoenhancement: evaluation with an anthropomorphic body CT phantom. Radiology 225 1 (2002) 83-90
79. Maki D.D., Birnbaum B.A., Chakraborty D.P., et al. Renal cyst pseudoenhancement: beam-hardening effects on CT numbers. Radiology 213 2 (1999) 468-472
80. Coulam C.H., Sheafor D.H., Leder R.A., et al. Evaluation of pseudoenhancement of renal cysts during contrast-enhanced CT. AJR Am J Roentgenol 174 2 (2000) 493-498
81. Bae K.T., Heiken J.P., Siegel C.L., et al. Renal cysts: is attenuation artifactually increased on contrast-enhanced CT images?. Radiology 216 3 (2000) 792-796
82. Heneghan J.P., Spielmann A.L., Sheafor D.H., et al. Pseudoenhancement of simple renal cysts: a comparison of single and multidetector helical CT. J Comput Assist Tomogr 26 1 (2002) 90-94
83. Gokan T., Ohgiya Y., Munechika H., et al. Renal cyst pseudoenhancement with beam hardening effect on CT attenuation. Radiat Med 20 4 (2002) 187-190
84. Abdulla C., Kalra M.K., Saini S., et al. Pseudoenhancement of simulated renal cysts in a phantom using different multidetector CT scanners. AJR Am J Roentgenol 179 6 (2002) 1473-1476
85. Pretorius E.S., Wickstrom M.L., and Siegelman E.S. MR imaging of renal neoplasms. Magn Reson Imaging Clin N Am 8 4 (2000) 813-836
86. Israel G.M., Hindman N., Hecht E., et al. The use of opposed-phase chemical shift MRI in the diagnosis of renal angiomyolipomas. AJR Am J Roentgenol 184 6 (2005) 1868-1872
87. Zhang J., Israel G.M., Krinsky G.A., et al. Masses and pseudomasses of the kidney: imaging spectrum on MR. J Comput Assist Tomogr 28 5 (2004) 588-595
88. Heiss S.G., Shifrin R.Y., and Sommer F.G. Contrast-enhanced three-dimensional fast spoiled gradient-echo renal MR imaging: evaluation of vascular and nonvascular disease. Radiographics 20 5 (2000) 1341-1352 [discussion 1353-4]
89. Semelka R.C., Hricak H., Stevens S.K., et al. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses. Radiology 178 3 (1991) 803-809
90. Eilenberg S.S., Lee J.K., Brown J., et al. Renal masses: evaluation with gradient-echo Gd-DTPA-enhanced dynamic MR imaging. Radiology 176 2 (1990) 333-338
91. Semelka R.C., Shoenut J.P., Kroeker M.A., et al. Renal lesions: controlled comparison between CT and 1.5-T MR imaging with nonenhanced and gadolinium-enhanced fat-suppressed spin-echo and breath-hold FLASH techniques. Radiology 182 2 (1992) 425-430
92. Bosniak M.A., and Rofsky N.M. Problems in the detection and characterization of small renal masses. Radiology 198 3 (1996) 638-641
93. John G., Semelka R.C., Burdeny D.A., et al. Renal cell cancer: incidence of hemorrhage on MR images in patients with chronic renal insufficiency. J Magn Reson Imaging 7 1 (1997) 157-160
94. Scialpi M., Di Maggio A., Midiri M., et al. Small renal masses: assessment of lesion characterization and vascularity on dynamic contrast-enhanced MR imaging with fat suppression. AJR Am J Roentgenol 175 3 (2000) 751-757
95. Fein A.B., Lee J.K., Balfe D.M., et al. Diagnosis and staging of renal cell carcinoma: a comparison of MR imaging and CT. AJR Am J Roentgenol 148 4 (1987) 749-753
96. Outwater E.K., Bhatia M., Siegelman E.S., et al. Lipid in renal clear cell carcinoma: detection on opposed-phase gradient-echo MR images. Radiology 205 1 (1997) 103-107
97. Outwater E.K., Blasbalg R., Siegelman E.S., et al. Detection of lipid in abdominal tissues with opposed-phase gradient-echo images at 1.5 T: techniques and diagnostic importance. Radiographics 18 6 (1998) 1465-1480
98. Ho V.B., Allen S.F., Hood M.N., et al. Renal masses: quantitative assessment of enhancement with dynamic MR imaging. Radiology 224 3 (2002) 695-700
99. Hecht E.M., Israel G.M., Krinsky G.A., et al. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology 232 2 (2004) 373-378
100. Israel G.M., Hindman N., and Bosniak M.A. Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. Radiology 231 2 (2004) 365-371
101. Hartman D.S., David Jr. C.J., Goldman S.M., et al. Renal lymphoma: radiologic-pathologic correlation of 21 cases. Radiology 144 4 (1982) 759-766
102. Forman H.P., Middleton W.D., Melson G.L., et al. Hyperechoic renal cell carcinomas: increase in detection at US. Radiology 188 2 (1993) 431-434
103. Prasad S.R., Saini S., Stewart S., et al. CT characterization of "indeterminate" renal masses: targeted or comprehensive scanning?. J Comput Assist Tomogr 26 5 (2002) 725-727
104. Helenon O., Chretien Y., Paraf F., et al. Renal cell carcinoma containing fat: demonstration with CT. Radiology 188 2 (1993) 429-430
105. Helenon O., Merran S., Paraf F., et al. Unusual fat-containing tumors of the kidney: a diagnostic dilemma. Radiographics 17 1 (1997) 129-144
106. Strotzer M., Lehner K.B., and Becker K. Detection of fat in a renal cell carcinoma mimicking angiomyolipoma. Radiology 188 2 (1993) 427-428
107. Taylor K.J., Ramos I., Carter D., et al. Correlation of Doppler US tumor signals with neovascular morphologic features. Radiology 166 1 Pt 1 (1988) 57-62
108. Tamai H., Takiguchi Y., Oka M., et al. Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors. J Ultrasound Med 24 12 (2005) 1635-1640
109. Kim J.K., Kim S.H., Jang Y.J., et al. Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging. Radiology 239 1 (2006) 174-180
110. Raj G.V., Bach A., Iasonos A., et al. Utility of pre-operative color Doppler ultrasonography in predicting the histology of renal lesions. J Urol 177 (2007) 53-58
111. Jinzaki M., Ohkuma K., Tanimoto A., et al. Small solid renal lesions: usefulness of power Doppler US. Radiology 209 2 (1998) 543-550
112. Warshauer D.M., McCarthy S.M., Street L., et al. Detection of renal masses: sensitivities and specificities of excretory urography/linear tomography, US, and CT. Radiology 169 2 (1988) 363-365
113. Jamis-Dow C.A., Choyke P.L., Jennings S.B., et al. Small (< or = 3-cm) renal masses: detection with CT versus US and pathologic correlation. Radiology 198 3 (1996) 785-788
114. Malaeb B.S., Martin D.J., Littooy F.N., et al. The utility of screening renal ultrasonography: identifying renal cell carcinoma in an elderly asymptomatic population. BJU Int 95 7 (2005) 977-981
115. Aide N., Cappele O., Bottet P., et al. Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT. Eur J Nucl Med Mol Imaging 30 9 (2003) 1236-1245
116. Goldberg M.A., Mayo-Smith W.W., Papanicolaou N., et al. FDG PET characterization of renal masses: preliminary experience. Clin Radiol 52 7 (1997) 510-515
117. Montravers F., Grahek D., Kerrou K., et al. Evaluation of FDG uptake by renal malignancies (primary tumor or metastases) using a coincidence detection gamma camera. J Nucl Med 41 1 (2000) 78-84
118. Ramdave S., Thomas G.W., Berlangieri S.U., et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol 166 3 (2001) 825-830
119. Blake M.A., McKernan M., Setty B., et al. Renal oncocytoma displaying intense activity on 18F-FDG PET. AJR Am J Roentgenol 186 1 (2006) 269-270
120. Schoder H., and Larson S.M. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 34 4 (2004) 274-292
121. Caoili E.M., Cohan R.H., Inampudi P., et al. MDCT urography of upper tract urothelial neoplasms. AJR Am J Roentgenol 184 6 (2005) 1873-1881
122. Rha S.E., Byun J.Y., Jung S.E., et al. The renal sinus: pathologic spectrum and multimodality imaging approach. Radiographics 24 Suppl 1 (2004) S117-S131
123. Urban B.A., Buckley J., Soyer P., et al. CT appearance of transitional cell carcinoma of the renal pelvis: Part 1. early-stage disease. AJR Am J Roentgenol 169 1 (1997) 157-161
124. Browne R.F., Meehan C.P., Colville J., et al. Transitional cell carcinoma of the upper urinary tract: spectrum of imaging findings. Radiographics 25 6 (2005) 1609-1627
125. Urban B.A., Buckley J., Soyer P., et al. CT appearance of transitional cell carcinoma of the renal pelvis: Part 2. advanced-stage disease. AJR Am J Roentgenol 169 1 (1997) 163-168
126. Wagle D.G., Moore R.H., and Murphy G.P. Secondary carcinomas of the kidney. J Urol 114 1 (1975) 30-32
127. Curry N.S. Small renal masses (lesions smaller than 3 cm): imaging evaluation and management. AJR Am J Roentgenol 164 2 (1995) 355-362
128. Israel G.M., and Krinsky G.A. MR imaging of the kidneys and adrenal glands. Radiol Clin North Am 41 1 (2003) 145-159
129. Cohan R.H., Dunnick N.R., Leder R.A., et al. Computed tomography of renal lymphoma. J Comput Assist Tomogr 14 6 (1990) 933-938
130. Urban B.A., and Fishman E.K. Renal lymphoma: CT patterns with emphasis on helical CT. Radiographics 20 1 (2000) 197-212
131. Heiken J.P., Gold R.P., Schnur M.J., et al. Computed tomography of renal lymphoma with ultrasound correlation. J Comput Assist Tomogr 7 2 (1983) 245-250
132. Vogelzang N.J., Fremgen A.M., Guinan P.D., et al. Primary renal sarcoma in adults: a natural history and management study by the American Cancer Society, Illinois Division. Cancer 71 3 (1993) 804-810
133. Shirkhoda A., and Lewis E. Renal sarcoma and sarcomatoid renal cell carcinoma: CT and angiographic features. Radiology 162 2 (1987) 353-357
134. Israel G.M., Bosniak M.A., Slywotzky C.M., et al. CT differentiation of large exophytic renal angiomyolipomas and perirenal liposarcomas. AJR Am J Roentgenol 179 3 (2002) 769-773
135. Nagar A.M., Raut A.A., Narlawar R.S., et al. Giant renal capsular leiomyoma: study of two cases. Br J Radiol 77 923 (2004) 957-958
136. Steiner M., Quinlan D., Goldman S.M., et al. Leiomyoma of the kidney: presentation of 4 new cases and the role of computerized tomography. J Urol 143 5 (1990) 994-998
137. Kidney. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th edition (2002), Springer, New York 323-325
138. Javidan J., Stricker H.J., Tamboli P., et al. Prognostic significance of the 1997 TNM classification of renal cell carcinoma. J Urol 162 4 (1999) 1277-1281
139. Johnson C.D., Dunnick N.R., Cohan R.H., et al. Renal adenocarcinoma: CT staging of 100 tumors. AJR Am J Roentgenol 148 1 (1987) 59-63
140. Yamashita Y., Honda S., Nishiharu T., et al. Detection of pseudocapsule of renal cell carcinoma with MR imaging and CT. AJR Am J Roentgenol 166 5 (1996) 1151-1155
141. Roy Sr. C., El Ghali S., Buy X., et al. Significance of the pseudocapsule on MRI of renal neoplasms and its potential application for local staging: a retrospective study. AJR Am J Roentgenol 184 1 (2005) 113-120
142. Gill I.S., McClennan B.L., Kerbl K., et al. Adrenal involvement from renal cell carcinoma: predictive value of computerized tomography. J Urol 152 4 (1994) 1082-1085
143. Didier D., Racle A., Etievent J.P., et al. Tumor thrombus of the inferior vena cava secondary to malignant abdominal neoplasms: US and CT evaluation. Radiology 162 1 Pt 1 (1987) 83-89
144. Studer U.E., Scherz S., Scheidegger J., et al. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 144 2 Pt 1 (1990) 243-245
145. Hilton S. Imaging of renal cell carcinoma. Semin Oncol 27 2 (2000) 150-159
146. Diederich S., Semik M., Lentschig M.G., et al. Helical CT of pulmonary nodules in patients with extrathoracic malignancy: CT-surgical correlation. AJR Am J Roentgenol 172 2 (1999) 353-360
147. Margaritora S., Porziella V., D'Andrilli A., et al. Pulmonary metastases: can accurate radiological evaluation avoid thoracotomic approach?. Eur J Cardiothorac Surg 21 6 (2002) 1111-1114
148. Raptopoulos V.D., Blake S.P., Weisinger K., et al. Multiphase contrast-enhanced helical CT of liver metastases from renal cell carcinoma. Eur Radiol 11 12 (2001) 2504-2509
149. Semelka R.C., Shoenut J.P., Magro C.M., et al. Renal cancer staging: comparison of contrast-enhanced CT and gadolinium-enhanced fat-suppressed spin-echo and gradient-echo MR imaging. J Magn Reson Imaging 3 4 (1993) 597-602
150. Myneni L., Hricak H., and Carroll P.R. Magnetic resonance imaging of renal carcinoma with extension into the vena cava: staging accuracy and recent advances. Br J Urol 68 6 (1991) 571-578
151. Cherrie R.J., Goldman D.G., Lindner A., et al. Prognostic implications of vena caval extension of renal cell carcinoma. J Urol 128 5 (1982) 910-912
152. Bissada N.K., Yakout H.H., Babanouri A., et al. Long-term experience with management of renal cell carcinoma involving the inferior vena cava. Urology 61 1 (2003) 89-92
153. Phillips E., and Messing E.M. Role of lymphadenectomy in the treatment of renal cell carcinoma. Urology 41 1 (1993) 9-15
154. Kavolius J.P., Mastorakos D.P., Pavlovich C., et al. Resection of metastatic renal cell carcinoma. J Clin Oncol 16 6 (1998) 2261-2266
155. Grimaldi G., Reuter V., and Russo P. Bilateral non-familial renal cell carcinoma. Ann Surg Oncol 5 6 (1998) 548-552
156. McKiernan J., Simmons R., Katz J., et al. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59 6 (2002) 816-820
157. Gilbert S.M., Russo P., Benson M.C., et al. The evolving role of partial nephrectomy in the management of renal cell carcinoma. Curr Oncol Rep 5 3 (2003) 239-244
158. Dash A., Vickers A.J., Schachter L.R., et al. Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4-7 cm. BJU Int 97 5 (2006) 939-945
159. Chernoff D.M., Silverman S.G., Kikinis R., et al. Three-dimensional imaging and display of renal tumors using spiral CT: a potential aid to partial nephrectomy. Urology 43 1 (1994) 125-129
160. Lee C.T., Hilton S., and Russo P. Renal mass within a horseshoe kidney: preoperative evaluation with three-dimensional helical computed tomography. Urology 57 1 (2001) 168
161. Pretorius E.S., Siegelman E.S., Ramchandani P., et al. Renal neoplasms amenable to partial nephrectomy: MR imaging. Radiology 212 1 (1999) 28-34
162. Lee C.T., Katz J., Fearn P.A., et al. Mode of presentation of renal cell carcinoma provides prognostic information. Urol Oncol 7 4 (2002) 135-140
163. Kattan M.W., Reuter V., Motzer R.J., et al. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166 1 (2001) 63-67
164. Duffey B.G., Choyke P.L., Glenn G., et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol 172 1 (2004) 63-65
165. Zagoria R.J., Hawkins A.D., Clark P.E., et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol 183 1 (2004) 201-207
166. Lewin J.S., Nour S.G., Connell C.F., et al. Phase II clinical trial of interactive MR imaging-guided interstitial radiofrequency thermal ablation of primary kidney tumors: initial experience. Radiology 232 3 (2004) 835-845
167. Silverman S.G., Tuncali K., vanSonnenberg E., et al. Renal tumors: MR imaging-guided percutaneous cryotherapy-initial experience in 23 patients. Radiology 236 2 (2005) 716-724
168. Gervais D.A., McGovern F.J., Wood B.J., et al. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 217 3 (2000) 665-672
169. Zagoria R.J. Percutaneous image-guided radiofrequency ablation of renal malignancies. Radiol Clin North Am 41 5 (2003) 1067-1075
170. McLaughlin C.A., Chen M.Y., Torti F.M., et al. Radiofrequency ablation of isolated local recurrence of renal cell carcinoma after radical nephrectomy. AJR Am J Roentgenol 181 1 (2003) 93-94
171. Zagoria R.J., Chen M.Y., Kavanagh P.V., et al. Radio frequency ablation of lung metastases from renal cell carcinoma. J Urol 166 5 (2001) 1827-1828
172. Wagner A.A., Solomon S.B., and Su L.M. Treatment of renal tumors with radiofrequency ablation. J Endourol 19 6 (2005) 643-652 [discussion 652-3]
173. Varkarakis I.M., Allaf M.E., Inagaki T., et al. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup. J Urol 174 2 (2005) 456-460 [discussion 460]
174. Su L.M., Jarrett T.W., Chan D.Y., et al. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results. Urology 61 4, Suppl 1 (2003) 26-33
175. Motzer R.J., and Russo P. Systemic therapy for renal cell carcinoma. J Urol 163 2 (2000) 408-417
176. Messing E.M., Manola J., Wilding G., et al. Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial. J Clin Oncol 21 7 (2003) 1214-1222
177. Clark J.I., Atkins M.B., Urba W.J., et al. Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial. J Clin Oncol 21 16 (2003) 3133-3140
178. Sandock D.S., Seftel A.D., and Resnick M.I. A new protocol for the followup of renal cell carcinoma based on pathological stage. J Urol 154 1 (1995) 28-31
179. Chae E.J., Kim J.K., Kim S.H., et al. Renal cell carcinoma: analysis of postoperative recurrence patterns. Radiology 234 1 (2005) 189-196
180. Sorbellini M., Kattan M.W., Snyder M.E., et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 173 1 (2005) 48-51